[Postoperative prognosis and treatment of valvular heart disease with cardiac cachexia from the view point of total pulmonary vascular resistance].
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage / Q000494:pharmacology; D002100:Cachexia / Q000150:complications*; D004614:Emaciation / Q000150:complications; D005260:Female; D006333:Heart Failure / Q000150:complications; D006349:Heart Valve Diseases / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011651:Pulmonary Artery / Q000503:physiopathology*; D011652:Pulmonary Circulation / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D000527:Alprostadil